Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2008, p. 3801-3804, Vol. 52, No. 10
0066-4804/08/$08.00+0 doi:10.1128/AAC.00638-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

INSERM U914 Emerging Resistance to Antibiotics, Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine et Université Paris-Sud, K.-Bicêtre,1 Service de Bactériologie-Virologie-Hygiène, Hôpital Henri Mondor, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine de Créteil, Université Paris XII, Créteil, France2
Received 15 May 2008/ Returned for modification 22 June 2008/ Accepted 12 July 2008
One hundred twenty-one extended-spectrum β-lactamse-producing enterobacterial clinical isolates were screened for the qepA gene. A single CTX-M-15-positive Escherichia coli isolate (0.8%) that produced the putative pump QepA2 was identified. This qepA2 gene was located onto a 90-kb mobilizable plasmid that conferred reduced susceptibility to hydrophilic fluoroquinolones.
Published ahead of print on 21 July 2008.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»